Phio Pharmaceuticals Corp.
PHIO· Nasdaq
Released Aug 6, 2026, after the close
10-Q filed Aug 6, 2026, 37 days after period end · 0001437749-26-026271
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Net Income | -$4.14M | -$2.17M | -$1.85M | -$2.55M |
| EPS Diluted | — | -$0.45 | -$3.62 | -$13.27 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Phio Pharmaceuticals Corp. · CIK 1533040 · Engraved from SEC EDGAR